BioPharm News

Aug 18, 2017
By BioPharm International Editors
The agency published guidance on identifying trading partners under DSCSA.
Aug 18, 2017
By BioPharm International Editors
FDA approves new molecular entity developed by Pfizer for treating a rare form of leukemia in adults.
Aug 18, 2017
By BioPharm International Editors
The International Society for Pharmaceutical Engineering (ISPE) announced its Europe Pharma 4.0 Conference, taking place November 23 – 24, 2017 in Verona, Italy.
Aug 17, 2017
By BioPharm International Editors
The company is voluntarily recalling Lorazepam Oral Concentrate, USP 2mg/mL because of misprinted dosing droppers.
Aug 16, 2017
By BioPharm International Editors
The US Patent and Trademark Office issued three new patents that extend protection for Alexion’s rare-disease drug, Soliris, for an additional 10 years.
Aug 16, 2017
By BioPharm International Editors
The $12-million acquisition will strengthen Cancer Genetics Inc.’s (CGI) capabilities in drug discovery, drug development, and early phase clinical trial testing in the field of oncology.
Aug 16, 2017
By BioPharm International Editors
A research collaboration joins Aslan with an academic research institute for studying small-molecule cancer drug candidates.
Aug 16, 2017
By BioPharm International Editors
GlaxoSmithKline (GSK) opened a new vaccine manufacturing facility in Montrose, Scotland. The £44 million (US$57 million) facility will be used to manufacture aluminum salts, which are used for vaccine production.
Aug 15, 2017
By BioPharm International Editors
The antibody therapeutic failed to meet its primary endpoint in a Phase III study.
Aug 14, 2017
By BioPharm International Editors
The agency sent a warning letter to Cellex-C International regarding GMP violations found at the company’s Toronto facility.
native1_300x100
lorem ipsum